Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 541 entries
Sorted by: Best Match Show Resources per page
The transition from high school to university: a medical student's perspective.

Advances in medical education and practice

Juma FZ, Abas T, Banu S.
PMID: 27672347
Adv Med Educ Pract. 2016 Sep 09;7:517-8. doi: 10.2147/AMEP.S114753. eCollection 2016.

No abstract available.

Cite
Juma FZ, Abas T, Banu S. The transition from high school to university: a medical student's perspective. Adv Med Educ Pract. 2016;7:517-8doi: 10.2147/AMEP.S114753.
Juma, F. Z., Abas, T., & Banu, S. (2016). The transition from high school to university: a medical student's perspective. Advances in medical education and practice, 7517-8. https://doi.org/10.2147/AMEP.S114753
Juma, Fatema Zehra, et al. "The transition from high school to university: a medical student's perspective." Advances in medical education and practice vol. 7 (2016): 517-8. doi: https://doi.org/10.2147/AMEP.S114753
Juma FZ, Abas T, Banu S. The transition from high school to university: a medical student's perspective. Adv Med Educ Pract. 2016 Sep 09;7:517-8. doi: 10.2147/AMEP.S114753. eCollection 2016. PMID: 27672347; PMCID: PMC5025003.
Copy Download .nbib Format: NLM
Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease.

Clinical kidney journal

Vega A, Abad S, Macías N, Aragoncillo I, Santos A, Galán I, Cedeño S, Manuel López-Gómez J.
PMID: 28396734
Clin Kidney J. 2017 Apr;10(2):170-175. doi: 10.1093/ckj/sfw126. Epub 2017 Feb 08.

No abstract available.

Cite
Vega A, Abad S, Macías N, et al. Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease. Clin Kidney J. 2017;10(2):170-175doi: 10.1093/ckj/sfw126.
Vega, A., Abad, S., Macías, N., Aragoncillo, I., Santos, A., Galán, I., Cedeño, S., & Manuel López-Gómez, J. (2017). Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease. Clinical kidney journal, 10(2), 170-175. https://doi.org/10.1093/ckj/sfw126
Vega, Almudena, et al. "Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease." Clinical kidney journal vol. 10,2 (2017): 170-175. doi: https://doi.org/10.1093/ckj/sfw126
Vega A, Abad S, Macías N, Aragoncillo I, Santos A, Galán I, Cedeño S, Manuel López-Gómez J. Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease. Clin Kidney J. 2017 Apr;10(2):170-175. doi: 10.1093/ckj/sfw126. Epub 2017 Feb 08. PMID: 28396734; PMCID: PMC5381238.
Copy Download .nbib Format: NLM
Stability Study of Algerian .

Journal of analytical methods in chemistry

Ahamad Bustamam MS, Hadithon KA, Mediani A, Abas F, Rukayadi Y, Lajis N, Shaari K, Safinar Ismail I.
PMID: 28255502
J Anal Methods Chem. 2017;2017:7891434. doi: 10.1155/2017/7891434. Epub 2017 Feb 01.

In a study to determine the stability of the main volatile constituents of

Cite
Ahamad Bustamam MS, Hadithon KA, Mediani A, et al. Stability Study of Algerian . J Anal Methods Chem. 2017;2017:7891434doi: 10.1155/2017/7891434.
Ahamad Bustamam, M. S., Hadithon, K. A., Mediani, A., Abas, F., Rukayadi, Y., Lajis, N., Shaari, K., & Safinar Ismail, I. (2017). Stability Study of Algerian . Journal of analytical methods in chemistry, 20177891434. https://doi.org/10.1155/2017/7891434
Ahamad Bustamam, Muhammad Safwan, et al. "Stability Study of Algerian ." Journal of analytical methods in chemistry vol. 2017 (2017): 7891434. doi: https://doi.org/10.1155/2017/7891434
Ahamad Bustamam MS, Hadithon KA, Mediani A, Abas F, Rukayadi Y, Lajis N, Shaari K, Safinar Ismail I. Stability Study of Algerian . J Anal Methods Chem. 2017;2017:7891434. doi: 10.1155/2017/7891434. Epub 2017 Feb 01. PMID: 28255502; PMCID: PMC5309406.
Copy Download .nbib Format: NLM
Association of Angiotensin-Converting Enzyme and Glutathione S-Transferase Gene Polymorphisms with Body Mass Index among Hypertensive North Indians.

Sultan Qaboos University medical journal

Rizvi S, Raza ST, Siddiqi Z, Abbas S, Mahdi F.
PMID: 26629373
Sultan Qaboos Univ Med J. 2015 Nov;15(4):e477-85. doi: 10.18295/squmj.2015.15.04.006. Epub 2015 Nov 23.

OBJECTIVES: This study aimed to examine the association of angiotensin-converting enzyme (ACE) and glutathione S-transferase (GST) gene polymorphisms with body mass index (BMI) in hypertensive North Indians.METHODS: This case-control study was carried out between May 2013 and November 2014...

Cite
Rizvi S, Raza ST, Siddiqi Z, et al. Association of Angiotensin-Converting Enzyme and Glutathione S-Transferase Gene Polymorphisms with Body Mass Index among Hypertensive North Indians. Sultan Qaboos Univ Med J. 2015;15(4):e477-85doi: 10.18295/squmj.2015.15.04.006.
Rizvi, S., Raza, S. T., Siddiqi, Z., Abbas, S., & Mahdi, F. (2015). Association of Angiotensin-Converting Enzyme and Glutathione S-Transferase Gene Polymorphisms with Body Mass Index among Hypertensive North Indians. Sultan Qaboos University medical journal, 15(4), e477-85. https://doi.org/10.18295/squmj.2015.15.04.006
Rizvi, Saliha, et al. "Association of Angiotensin-Converting Enzyme and Glutathione S-Transferase Gene Polymorphisms with Body Mass Index among Hypertensive North Indians." Sultan Qaboos University medical journal vol. 15,4 (2015): e477-85. doi: https://doi.org/10.18295/squmj.2015.15.04.006
Rizvi S, Raza ST, Siddiqi Z, Abbas S, Mahdi F. Association of Angiotensin-Converting Enzyme and Glutathione S-Transferase Gene Polymorphisms with Body Mass Index among Hypertensive North Indians. Sultan Qaboos Univ Med J. 2015 Nov;15(4):e477-85. doi: 10.18295/squmj.2015.15.04.006. Epub 2015 Nov 23. PMID: 26629373; PMCID: PMC4664091.
Copy Download .nbib Format: NLM
Diabetic Kidney Disease and Hypertension: A True Love Story.

Journal of clinical and diagnostic research : JCDR

Verma A, Vyas S, Agarwal A, Abbas S, Agarwal DP, Kumar R.
PMID: 27134912
J Clin Diagn Res. 2016 Mar;10(3):OC11-3. doi: 10.7860/JCDR/2016/18806.7511. Epub 2016 Mar 01.

INTRODUCTION: Diabetes Mellitus (DM) remains one of the commonest causes of structural and functional kidney abnormalities leading to End Stage Renal Disease (ESRD). The next most common cause is hypertension. It is utmost important to investigate the association between...

Cite
Verma A, Vyas S, Agarwal A, et al. Diabetic Kidney Disease and Hypertension: A True Love Story. J Clin Diagn Res. 2016;10(3):OC11-3doi: 10.7860/JCDR/2016/18806.7511.
Verma, A., Vyas, S., Agarwal, A., Abbas, S., Agarwal, D. P., & Kumar, R. (2016). Diabetic Kidney Disease and Hypertension: A True Love Story. Journal of clinical and diagnostic research : JCDR, 10(3), OC11-3. https://doi.org/10.7860/JCDR/2016/18806.7511
Verma, Anand, et al. "Diabetic Kidney Disease and Hypertension: A True Love Story." Journal of clinical and diagnostic research : JCDR vol. 10,3 (2016): OC11-3. doi: https://doi.org/10.7860/JCDR/2016/18806.7511
Verma A, Vyas S, Agarwal A, Abbas S, Agarwal DP, Kumar R. Diabetic Kidney Disease and Hypertension: A True Love Story. J Clin Diagn Res. 2016 Mar;10(3):OC11-3. doi: 10.7860/JCDR/2016/18806.7511. Epub 2016 Mar 01. PMID: 27134912; PMCID: PMC4843298.
Copy Download .nbib Format: NLM
Integrated Process Modeling-A Process Validation Life Cycle Companion.

Bioengineering (Basel, Switzerland)

Zahel T, Hauer S, Mueller EM, Murphy P, Abad S, Vasilieva E, Maurer D, Brocard C, Reinisch D, Sagmeister P, Herwig C.
PMID: 29039771
Bioengineering (Basel). 2017 Oct 17;4(4). doi: 10.3390/bioengineering4040086.

During the regulatory requested process validation of pharmaceutical manufacturing processes, companies aim to identify, control, and continuously monitor process variation and its impact on critical quality attributes (CQAs) of the final product. It is difficult to directly connect the...

Cite
Zahel T, Hauer S, Mueller EM, et al. Integrated Process Modeling-A Process Validation Life Cycle Companion. Bioengineering (Basel). 2017;4(4)doi: 10.3390/bioengineering4040086.
Zahel, T., Hauer, S., Mueller, E. M., Murphy, P., Abad, S., Vasilieva, E., Maurer, D., Brocard, C., Reinisch, D., Sagmeister, P., & Herwig, C. (2017). Integrated Process Modeling-A Process Validation Life Cycle Companion. Bioengineering (Basel, Switzerland), 4(4), . https://doi.org/10.3390/bioengineering4040086
Zahel, Thomas, et al. "Integrated Process Modeling-A Process Validation Life Cycle Companion." Bioengineering (Basel, Switzerland) vol. 4,4 (2017). doi: https://doi.org/10.3390/bioengineering4040086
Zahel T, Hauer S, Mueller EM, Murphy P, Abad S, Vasilieva E, Maurer D, Brocard C, Reinisch D, Sagmeister P, Herwig C. Integrated Process Modeling-A Process Validation Life Cycle Companion. Bioengineering (Basel). 2017 Oct 17;4(4). doi: 10.3390/bioengineering4040086. PMID: 29039771; PMCID: PMC5746753.
Copy Download .nbib Format: NLM
Mental health and human trafficking: responding to survivors' needs.

BJPsych international

Altun S, Abas M, Zimmerman C, Howard LM, Oram S.
PMID: 29093930
BJPsych Int. 2017 Feb 01;14(1):21-23. doi: 10.1192/s205647400000163x. eCollection 2017 Feb.

Mental health professionals have opportunities to intervene and provide care for trafficked people. Research shows that mental health problems - including depression, anxiety and post-traumatic stress disorder - are prevalent among trafficked people, and that at least some trafficked...

Cite
Altun S, Abas M, Zimmerman C, et al. Mental health and human trafficking: responding to survivors' needs. BJPsych Int. 2017;14(1):21-23doi: 10.1192/s205647400000163x.
Altun, S., Abas, M., Zimmerman, C., Howard, L. M., & Oram, S. (2017). Mental health and human trafficking: responding to survivors' needs. BJPsych international, 14(1), 21-23. https://doi.org/10.1192/s205647400000163x
Altun, Sukran, et al. "Mental health and human trafficking: responding to survivors' needs." BJPsych international vol. 14,1 (2017): 21-23. doi: https://doi.org/10.1192/s205647400000163x
Altun S, Abas M, Zimmerman C, Howard LM, Oram S. Mental health and human trafficking: responding to survivors' needs. BJPsych Int. 2017 Feb 01;14(1):21-23. doi: 10.1192/s205647400000163x. eCollection 2017 Feb. PMID: 29093930; PMCID: PMC5618827.
Copy Download .nbib Format: NLM
Anticoagulant Activity of Polyphenolic-Polysaccharides Isolated from Melastoma malabathricum L.

Evidence-based complementary and alternative medicine : eCAM

Khoo LT, Abas F, Abdullah JO, Mohd Tohit ER, Hamid M.
PMID: 24987430
Evid Based Complement Alternat Med. 2014;2014:614273. doi: 10.1155/2014/614273. Epub 2014 May 20.

Melastoma malabathricum Linn. is a perennial traditional medicine plants that grows abundantly throughout Asian countries. In this study, M. malabathricum Linn. leaf hot water crude extract with anticoagulant activity was purified through solid phase extraction cartridge and examined for...

Cite
Khoo LT, Abas F, Abdullah JO, et al. Anticoagulant Activity of Polyphenolic-Polysaccharides Isolated from Melastoma malabathricum L. Evid Based Complement Alternat Med. 2014;2014:614273doi: 10.1155/2014/614273.
Khoo, L. T., Abas, F., Abdullah, J. O., Mohd Tohit, E. R., & Hamid, M. (2014). Anticoagulant Activity of Polyphenolic-Polysaccharides Isolated from Melastoma malabathricum L. Evidence-based complementary and alternative medicine : eCAM, 2014614273. https://doi.org/10.1155/2014/614273
Khoo, Li Teng, et al. "Anticoagulant Activity of Polyphenolic-Polysaccharides Isolated from Melastoma malabathricum L." Evidence-based complementary and alternative medicine : eCAM vol. 2014 (2014): 614273. doi: https://doi.org/10.1155/2014/614273
Khoo LT, Abas F, Abdullah JO, Mohd Tohit ER, Hamid M. Anticoagulant Activity of Polyphenolic-Polysaccharides Isolated from Melastoma malabathricum L. Evid Based Complement Alternat Med. 2014;2014:614273. doi: 10.1155/2014/614273. Epub 2014 May 20. PMID: 24987430; PMCID: PMC4054800.
Copy Download .nbib Format: NLM
Workflow for Criticality Assessment Applied in Biopharmaceutical Process Validation Stage 1.

Bioengineering (Basel, Switzerland)

Zahel T, Marschall L, Abad S, Vasilieva E, Maurer D, Mueller EM, Murphy P, Natschläger T, Brocard C, Reinisch D, Sagmeister P, Herwig C.
PMID: 29023375
Bioengineering (Basel). 2017 Oct 12;4(4). doi: 10.3390/bioengineering4040085.

Identification of critical process parameters that impact product quality is a central task during regulatory requested process validation. Commonly, this is done via design of experiments and identification of parameters significantly impacting product quality (rejection of the null hypothesis...

Cite
Zahel T, Marschall L, Abad S, et al. Workflow for Criticality Assessment Applied in Biopharmaceutical Process Validation Stage 1. Bioengineering (Basel). 2017;4(4)doi: 10.3390/bioengineering4040085.
Zahel, T., Marschall, L., Abad, S., Vasilieva, E., Maurer, D., Mueller, E. M., Murphy, P., Natschläger, T., Brocard, C., Reinisch, D., Sagmeister, P., & Herwig, C. (2017). Workflow for Criticality Assessment Applied in Biopharmaceutical Process Validation Stage 1. Bioengineering (Basel, Switzerland), 4(4), . https://doi.org/10.3390/bioengineering4040085
Zahel, Thomas, et al. "Workflow for Criticality Assessment Applied in Biopharmaceutical Process Validation Stage 1." Bioengineering (Basel, Switzerland) vol. 4,4 (2017). doi: https://doi.org/10.3390/bioengineering4040085
Zahel T, Marschall L, Abad S, Vasilieva E, Maurer D, Mueller EM, Murphy P, Natschläger T, Brocard C, Reinisch D, Sagmeister P, Herwig C. Workflow for Criticality Assessment Applied in Biopharmaceutical Process Validation Stage 1. Bioengineering (Basel). 2017 Oct 12;4(4). doi: 10.3390/bioengineering4040085. PMID: 29023375; PMCID: PMC5746752.
Copy Download .nbib Format: NLM
Male child with somatic mosaic Osteopathia Striata with Cranial Sclerosis caused by a novel pathogenic AMER1 frameshift mutation.

American journal of medical genetics. Part A

Hague J, Delon I, Brugger K, Martin H, Sparnon L, Simonic I, Abbs S, Park SM.
PMID: 28497491
Am J Med Genet A. 2017 Jul;173(7):1931-1935. doi: 10.1002/ajmg.a.38261. Epub 2017 May 12.

Osteopathia striata with cranial sclerosis (OSCS; OMIM #300373) is a rare X-linked dominant condition caused by mutations in the AMER1 gene (also known as WTX or FAM123B). It is a condition which usually affects females in whom the clinical...

Cite
Hague J, Delon I, Brugger K, et al. Male child with somatic mosaic Osteopathia Striata with Cranial Sclerosis caused by a novel pathogenic AMER1 frameshift mutation. Am J Med Genet A. 2017;173(7):1931-1935doi: 10.1002/ajmg.a.38261.
Hague, J., Delon, I., Brugger, K., Martin, H., Sparnon, L., Simonic, I., Abbs, S., & Park, S. M. (2017). Male child with somatic mosaic Osteopathia Striata with Cranial Sclerosis caused by a novel pathogenic AMER1 frameshift mutation. American journal of medical genetics. Part A, 173(7), 1931-1935. https://doi.org/10.1002/ajmg.a.38261
Hague, Jennifer, et al. "Male child with somatic mosaic Osteopathia Striata with Cranial Sclerosis caused by a novel pathogenic AMER1 frameshift mutation." American journal of medical genetics. Part A vol. 173,7 (2017): 1931-1935. doi: https://doi.org/10.1002/ajmg.a.38261
Hague J, Delon I, Brugger K, Martin H, Sparnon L, Simonic I, Abbs S, Park SM. Male child with somatic mosaic Osteopathia Striata with Cranial Sclerosis caused by a novel pathogenic AMER1 frameshift mutation. Am J Med Genet A. 2017 Jul;173(7):1931-1935. doi: 10.1002/ajmg.a.38261. Epub 2017 May 12. PMID: 28497491.
Copy Download .nbib Format: NLM
Association of angiotensin-converting enzyme, .

Oman journal of ophthalmology

Raza ST, Abbas S, Chandra A, Singh L, Rizvi S, Mahdi F.
PMID: 28298860
Oman J Ophthalmol. 2017 Jan-Apr;10(1):21-25. doi: 10.4103/ojo.OJO_40_2015.

RESULTS: This study included 103 senile cataract cases (55 were males and 48 were females) and 102 controls (53 were males and 49 were females). Mean age of cases in this study was 52.02 ± 12.11 years while in...

Cite
Raza ST, Abbas S, Chandra A, et al. Association of angiotensin-converting enzyme, . Oman J Ophthalmol. 2017;10(1):21-25doi: 10.4103/ojo.OJO_40_2015.
Raza, S. T., Abbas, S., Chandra, A., Singh, L., Rizvi, S., & Mahdi, F. (2017). Association of angiotensin-converting enzyme, . Oman journal of ophthalmology, 10(1), 21-25. https://doi.org/10.4103/ojo.OJO_40_2015
Raza, Syed Tasleem, et al. "Association of angiotensin-converting enzyme, ." Oman journal of ophthalmology vol. 10,1 (2017): 21-25. doi: https://doi.org/10.4103/ojo.OJO_40_2015
Raza ST, Abbas S, Chandra A, Singh L, Rizvi S, Mahdi F. Association of angiotensin-converting enzyme, . Oman J Ophthalmol. 2017 Jan-Apr;10(1):21-25. doi: 10.4103/ojo.OJO_40_2015. PMID: 28298860; PMCID: PMC5338047.
Copy Download .nbib Format: NLM
Hepatitis D and hepatocellular carcinoma.

World journal of hepatology

Abbas Z, Abbas M, Abbas S, Shazi L.
PMID: 25914778
World J Hepatol. 2015 Apr 18;7(5):777-86. doi: 10.4254/wjh.v7.i5.777.

Hepatitis D virus (HDV) is a defective circular shape single stranded HDV RNA virus with two types of viral proteins, small and large hepatitis D antigens, surrounded by hepatitis B surface antigen. Superinfection with HDV in chronic hepatitis B...

Cite
Abbas Z, Abbas M, Abbas S, et al. Hepatitis D and hepatocellular carcinoma. World J Hepatol. 2015;7(5):777-86doi: 10.4254/wjh.v7.i5.777.
Abbas, Z., Abbas, M., Abbas, S., & Shazi, L. (2015). Hepatitis D and hepatocellular carcinoma. World journal of hepatology, 7(5), 777-86. https://doi.org/10.4254/wjh.v7.i5.777
Abbas, Zaigham, et al. "Hepatitis D and hepatocellular carcinoma." World journal of hepatology vol. 7,5 (2015): 777-86. doi: https://doi.org/10.4254/wjh.v7.i5.777
Abbas Z, Abbas M, Abbas S, Shazi L. Hepatitis D and hepatocellular carcinoma. World J Hepatol. 2015 Apr 18;7(5):777-86. doi: 10.4254/wjh.v7.i5.777. PMID: 25914778; PMCID: PMC4404383.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 541 entries